NCRC
The 2019 Novel Coronavirus Research Compendium (NCRC) is a centralized, publicly available resource that rapidly curates and reviews the emerging scientific evidence about SARS-CoV-2 and COVID-19. Our goal is to provide accurate, relevant information for global public health action by clinicians, public health practitioners, and policy makers.
Latest preprint reviews
-
Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain
This article has 13 authors: -
Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy
This article has 24 authors: -
Phase II Clinical trial for Evaluation of BCG as potential therapy for COVID-19
This article has 5 authors: -
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
This article has 29 authors: -
Airborne contamination of COVID-19 in hospitals: a scoping review of the current evidence
This article has 6 authors: -
A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey
This article has 2 authors: -
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
This article has 11 authors:Reviewed by ScreenIT, Rapid Reviews Infectious Diseases, NCRC
-
Characteristics Associated With Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Ontario, Canada: A Cohort Study
This article has 8 authors: -
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
This article has 22 authors: -
Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection of a Healthcare Worker in a Belgian Nosocomial Outbreak Despite Primary Neutralizing Antibody Response
This article has 9 authors: